Skip to Main Content

Introducing STAT’s Biotech Q3 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep, or broken heart — whatever captures the mood. We’ll also be updating this page with more in-depth previews of the biotech events to help you better prepare for their arrival.


Read on for brief explanations of what we’re watching for from each company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.